The pharmaceutical industry is seeing a significant uptick in cyber-attacks targeting research patents and trade secrets. Targeted attacks are becoming more advanced and require an approach that can detect malicious zero-day type attacks.
With siloed endpoint and security monitoring tools, the organization was receiving low fidelity alerts without adequate context and prioritization. This increased the time and resources needed to investigate threats, putting the organization at a significant risk of a data breach.
In order to enhance their threat detection capability, the organization integrated their Tanium and Securonix solutions and implemented the out-of-the-box Tanium use cases Securonix provides to detect and prioritize threats that would otherwise go unnoticed.
Download this case study to find out more.